These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29190965)

  • 1. Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy.
    Li N; Liu X; Zhai F; Liu B; Cao X; Li S; Zhang M; Liu M
    Oncotarget; 2017 Nov; 8(54):92904-92913. PubMed ID: 29190965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating
    Franco P; Fiandra C; Arcadipane F; Trino E; Giglioli FR; Ragona R; Ricardi U
    BMC Cancer; 2017 Nov; 17(1):710. PubMed ID: 29096619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
    Franco P; Ragona R; Arcadipane F; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
    Med Oncol; 2016 Dec; 33(12):137. PubMed ID: 27815805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy.
    Newman NB; Sidhu MK; Baby R; Moss RA; Nissenblatt MJ; Chen T; Lu SE; Jabbour SK
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1052-60. PubMed ID: 27026312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.
    Franco P; Ragona R; Arcadipane F; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
    Clin Transl Oncol; 2017 Jan; 19(1):67-75. PubMed ID: 27037814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
    Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Cassoni P; Arena V; Bustreo S; Faletti R; Rondi N; Morino M; Ricardi U
    Med Oncol; 2016 Jul; 33(7):72. PubMed ID: 27277756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy.
    Huang W; Dang J; Li Y; Cui HX; Lu WL; Jiang QF
    Front Oncol; 2021; 11():646211. PubMed ID: 33968746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy.
    Chen M; Wang D; Bao Z; Yi Z; Mei Z; Sun S; Xiang Q; Yang C; Yang H; Qiu H; Xie C
    Radiat Oncol; 2023 Apr; 18(1):66. PubMed ID: 37031167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Mell LK; Schomas DA; Salama JK; Devisetty K; Aydogan B; Miller RC; Jani AB; Kindler HL; Mundt AJ; Roeske JC; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1431-7. PubMed ID: 17996390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy.
    Bazan JG; Luxton G; Kozak MM; Anderson EM; Hancock SL; Kapp DS; Kidd EA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):983-91. PubMed ID: 24161422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.
    Rose B; Mitra D; Hong TS; Jee KW; Niemierko A; Drapek LN; Blaszkowsky LS; Allen JN; Murphy JE; Clark JW; Ryan DP; Wo JY
    Pract Radiat Oncol; 2017; 7(5):e291-e297. PubMed ID: 28462895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbosacral spine and marrow cavity modeling of acute hematologic toxicity in patients treated with intensity modulated radiation therapy for squamous cell carcinoma of the anal canal.
    Cheng JC; Bazan JG; Wu JK; Koong AC; Chang DT
    Pract Radiat Oncol; 2014; 4(3):198-206. PubMed ID: 24766688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of radiotherapy time and dose on acute hematologic toxicity during concurrent postoperative chemoradiotherapy for early high-risk cervical cancer.
    Yang X; Li Z; Zhang L; Li H; Yang X; Sun Y; Liu L; Fu J
    J Cancer; 2023; 14(6):895-902. PubMed ID: 37151393
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of pelvic bone marrow irradiation on the hematological toxicity of subsequent chemotherapy in rectal cancer.
    Spalek M; Michalski W; Wyrwicz L
    Neoplasma; 2019 Mar; 66(2):276-280. PubMed ID: 30569718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
    Kumar T; Schernberg A; Busato F; Laurans M; Fumagalli I; Dumas I; Deutsch E; Haie-Meder C; Chargari C
    Cancer Manag Res; 2019; 11():6285-6297. PubMed ID: 31372035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer.
    Zhang BZ; Li Y; Xu LM; Chai YL; Qu C; Cao YJ; Wang J; Hou HL; Zhang J
    Radiat Oncol; 2023 Jan; 18(1):12. PubMed ID: 36658595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy.
    Rahimy E; von Eyben R; Lewis J; Hristov D; Kidd E
    Strahlenther Onkol; 2022 Sep; 198(9):773-782. PubMed ID: 35059758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer.
    Wang Q; Ye T; Chen HL; Zhang XG; Zhang LZ
    Eur Rev Med Pharmacol Sci; 2016; 20(1):75-81. PubMed ID: 26813456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.